Related Experiment Video
Updated: Oct 10, 2025

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Ligneous conjunctivitis exacerbated by Pseudomonas aeruginosa - Diagnostic and therapeutic approach
Madiha Tariq1, Muhammad Abdullah Zahid2, Taimoor Ashraf Khan3
1Unit 1, Institute of Ophthalmology, Mayo Hospital, Lahore, Pakistan.
Abstract:
Ligneous conjunctivitis is a rare disease in which pseudomembranes develop on the mucosal surfaces of the eye. Only a handful of cases have been reported in the past 100 years. Although plasminogen deficiency is largely implicated in the pathogenesis of this condition, infectious agents are also thought to play a role in worsening the disease. Treatment is usually challenging. We present a case of 3-year-old female in whom a multidrug-resistant Pseudomonas aeruginosa was isolated from the culture of the pseudomembranes. To the best of our knowledge, this is the first time P. aeruginosa has been implicated as an exacerbation factor. Furthermore, we have given merit to the triple regimen of corticosteroids, heparin, and cyclosporine as being effective. We also added antibiotics to target the infectious organism.
Insights
Ligneous conjunctivitis, a rare eye disease, can be worsened by multidrug-resistant Pseudomonas aeruginosa. A novel triple therapy combined with antibiotics proved effective in a pediatric case.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Genetics
Background:
- Ligneous conjunctivitis is a rare, chronic inflammatory condition characterized by pseudomembrane formation on ocular mucosal surfaces.
- Plasminogen deficiency is the primary suspected cause, but infectious agents may exacerbate the disease.
- Treatment for ligneous conjunctivitis is often challenging and requires a multifaceted approach.
Observation:
- A 3-year-old female presented with ligneous conjunctivitis.
- Cultures from the pseudomembranes isolated a multidrug-resistant strain of Pseudomonas aeruginosa.
- This marks the first reported instance of P. aeruginosa involvement in exacerbating ligneous conjunctivitis.
Findings:
- A multidrug-resistant Pseudomonas aeruginosa strain was identified as a potential exacerbating factor in a pediatric case of ligneous conjunctivitis.
- A treatment regimen combining corticosteroids, heparin, and cyclosporine, supplemented with targeted antibiotics, demonstrated efficacy.
- This case highlights the potential role of bacterial infections in the pathogenesis and exacerbation of ligneous conjunctivitis.
Implications:
- The findings suggest that infectious agents, specifically multidrug-resistant Pseudomonas aeruginosa, can play a significant role in the exacerbation of ligneous conjunctivitis.
- The successful use of a triple therapy regimen (corticosteroids, heparin, cyclosporine) plus antibiotics offers a promising therapeutic strategy for complex cases.
- This case underscores the importance of identifying and treating infectious agents in ligneous conjunctivitis for improved patient outcomes.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Acute Pyelonephritis II: Diagnostic Studies and Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

